🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 3 Months
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(3727)
All (3727)
Buys (380)
Sells (3347)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Travere Therapeutics, Inc.
(TVTX)
ROTE WILLIAM E.
— Chief Research Officer
Apr 22, 2026
Sale
Shares
9,100
Price
$39.09
Total Value
$355.72K
Shares Held After
113,987
% of Holdings
7.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
21
Price
$173.04
Total Value
$3.63K
Shares Held After
10,666
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
249
Price
$172.49
Total Value
$42.95K
Shares Held After
10,687
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
257
Price
$171.62
Total Value
$44.11K
Shares Held After
10,936
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
75
Price
$170.58
Total Value
$12.79K
Shares Held After
11,193
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
105
Price
$169.52
Total Value
$17.80K
Shares Held After
11,268
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
101
Price
$168.64
Total Value
$17.03K
Shares Held After
11,373
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
141
Price
$167.42
Total Value
$23.61K
Shares Held After
11,474
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
20
Price
$166.32
Total Value
$3.33K
Shares Held After
11,615
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BELITE BIO, INC
(BLTE)
MATA NATHAN L.
— Chief Scientific Officer
Apr 22, 2026
Sale
Shares
31
Price
$165.70
Total Value
$5.14K
Shares Held After
11,635
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SANGAMO THERAPEUTICS, INC
(SGMO)
Davis Gregory D
— Head of Research & Technology
Apr 22, 2026
Sale
Shares
69,827
Price
$0.25
Total Value
$17.69K
Shares Held After
115,284
% of Holdings
37.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Kersten Dirk
— Director
Apr 22, 2026
Sale
Shares
2,652
Price
$20.00
Total Value
$53.05K
Shares Held After
4,196,573
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioNTech SE
(BNTX)
Poetting Sierk
— Chief Operating Officer
Apr 22, 2026
Sale
Shares
50,000
Price
$110.56
Total Value
$5.53M
Shares Held After
399,387
% of Holdings
11.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Aditxt, Inc.
(ADTX)
HRT FINANCIAL LP
— 10% Owner
Apr 22, 2026
Sale
Shares
11,982
Price
$0.30
Total Value
$3.59K
Shares Held After
121,592
% of Holdings
9.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nasus Pharma Ltd
(NSRX)
Teleman Dan Benjamin
— Director
Apr 22, 2026
Purchase
Shares
2,900
Price
$3.76
Total Value
$10.90K
Shares Held After
156,991
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Rhodes Jason P
— Director
Apr 22, 2026
Sale
Shares
59,663
Price
$19.68
Total Value
$1.17M
Shares Held After
1,285,704
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Rhodes Jason P
— Director
Apr 22, 2026
Sale
Shares
1,485
Price
$19.68
Total Value
$29.22K
Shares Held After
11,663
% of Holdings
11.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Rhodes Jason P
— Director
Apr 22, 2026
Sale
Shares
150,942
Price
$19.68
Total Value
$2.97M
Shares Held After
5,260,179
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dyne Therapeutics, Inc.
(DYN)
Rhodes Jason P
— Director
Apr 22, 2026
Sale
Shares
75,866
Price
$19.68
Total Value
$1.49M
Shares Held After
1,738,617
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 3101–3150 of 3727 transactions (page 63 of 75)
Version: v26.7.3